Development of a novel screen for protease inhibitors

被引:3
作者
Gillim, L
Gusella, GL
Vargas, J
Marras, D
Klotman, ME
Cara, A
机构
[1] CUNY Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA
[3] Ist Super Sanita, I-00161 Rome, Italy
关键词
D O I
10.1128/CDLI.8.2.437-440.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have developed a novel plasmid-based, quantitative, in vitro screen to test the protease-inhibiting activities of existing and newly discovered agents.
引用
收藏
页码:437 / 440
页数:4
相关论文
共 9 条
[1]   POTENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY INDUCIBLE EXPRESSION OF HIV-1 PR MULTIMERS [J].
ARRIGO, SJ ;
HUFFMAN, K .
JOURNAL OF VIROLOGY, 1995, 69 (10) :5988-5994
[2]   Viral proteases: Evolution of diverse structural motifs to optimize function [J].
Babe, LM ;
Craik, CS .
CELL, 1997, 91 (04) :427-430
[3]   Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated enzymes [J].
Marcel, V ;
Estrada-Mondaca, S ;
Magné, F ;
Stojan, J ;
Klaébé, A ;
Fournier, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :11603-11609
[4]   An Escherichia coli expression assay and screen for human immunodeficiency virus protease variants with decreased susceptibility to indinavir [J].
Melnick, L ;
Yang, SS ;
Rossi, R ;
Zepp, C ;
Heefner, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3256-3265
[5]   Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus [J].
Molla, A ;
Vasavanonda, S ;
Kumar, G ;
Sham, HL ;
Johnson, M ;
Grabowski, B ;
Denissen, JF ;
Kohlbrenner, W ;
Plattner, JJ ;
Leonard, JM ;
Norbeck, DW ;
Kempf, DJ .
VIROLOGY, 1998, 250 (02) :255-262
[6]   Use of GFP as a reporter for the facile analysis of sequence-specific proteases [J].
Pehrson, JC ;
Weatherman, A ;
Markwell, J ;
Sarath, G ;
Schwartzbach, SD .
BIOTECHNIQUES, 1999, 27 (01) :28-+
[7]   Epitope-based assay to determine the efficiency of cleavage by HIV-1 protease [J].
Serio, D ;
Weber, IT ;
Harrison, RW ;
Louis, JM ;
Srinivasan, A .
BIOTECHNIQUES, 1999, 26 (02) :242-+
[8]   Development of in vitro peptide substrates for human rhinovirus-14 2A protease [J].
Wang, QM ;
Johnson, RB ;
Sommergruber, W ;
Shepherd, TA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 356 (01) :12-18
[9]  
Yamamoto T, 1998, BIOL PHARM BULL, V21, P1148